Mind Medicine (MindMed) Inc. Stock Other OTC
Equities
MMEDF
CA60255C1095
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 628M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -106M | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M | Net cash position 2025 * | 99.5M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.61
x | P/E ratio 2025 * |
-6.07
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.59% |
Latest transcript on Mind Medicine (MindMed) Inc.
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 21-01-13 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22-05-22 |
Miri Wernli
PSD | President | 71 | 20-02-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 21-09-28 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 22-08-10 |
David Gryska
BRD | Director/Board Member | 68 | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |